Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkers

By Castellano, Daniel | De Velasco, Guillermo. Cancer Treatment Reviews, 2013 . 39(3):230-240. , Formato Vancouver: Castellano D, Ravaud A, Schmidinger M, De Velasco G, Vázquez F. Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkers. Cancer Treat Rev. 2013;39(3):230-40.

Place Hold on Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkers

Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature.

By De Velasco, Guillermo | Muñoz, César | Sepúlveda Sánchez, Juan Manuel | Castellano, Daniel. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2015 . 9(3-4):E243-6. , Formato Vancouver: de Velasco G, Munoz C, Sepulveda JM, Castellano D. Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature. Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E243-6.

Place Hold on Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature.

Search for 'an:"882" and au:De Velasco, Guillermo and au:Castellano, Daniel'

Therapy management with sunitinib in patients with metastatic renal cell carcinoma: key concepts and the impact of clinical biomarkers

Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature.